Sanara Medtech Inc
NASDAQ:SMTI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
26.86
41.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SMTI stock under the Base Case scenario is 41.28 USD. Compared to the current market price of 37.7 USD, Sanara Medtech Inc is Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Sanara Medtech Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SMTI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Sanara Medtech Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Sanara Medtech Inc
Balance Sheet Decomposition
Sanara Medtech Inc
Current Assets | 31.9m |
Cash & Short-Term Investments | 16.3m |
Receivables | 12.2m |
Other Current Assets | 3.4m |
Non-Current Assets | 56.6m |
Long-Term Investments | 8.3m |
PP&E | 2.7m |
Intangibles | 45.6m |
Other Non-Current Assets | 10 |
Current Liabilities | 14.3m |
Accounts Payable | 1.5m |
Accrued Liabilities | 11m |
Other Current Liabilities | 1.9m |
Non-Current Liabilities | 34.4m |
Long-Term Debt | 30.1m |
Other Non-Current Liabilities | 4.3m |
Earnings Waterfall
Sanara Medtech Inc
Revenue
|
78.1m
USD
|
Cost of Revenue
|
-7.7m
USD
|
Gross Profit
|
70.4m
USD
|
Operating Expenses
|
-76.9m
USD
|
Operating Income
|
-6.6m
USD
|
Other Expenses
|
-1.8m
USD
|
Net Income
|
-8.4m
USD
|
Free Cash Flow Analysis
Sanara Medtech Inc
USD | |
Free Cash Flow | USD |
SMTI Profitability Score
Profitability Due Diligence
Sanara Medtech Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Sanara Medtech Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
SMTI Solvency Score
Solvency Due Diligence
Sanara Medtech Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Sanara Medtech Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SMTI Price Targets Summary
Sanara Medtech Inc
According to Wall Street analysts, the average 1-year price target for SMTI is 44.88 USD with a low forecast of 44.44 USD and a high forecast of 46.2 USD.
Dividends
Current shareholder yield for SMTI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SMTI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.
Contact
IPO
Employees
Officers
The intrinsic value of one SMTI stock under the Base Case scenario is 41.28 USD.
Compared to the current market price of 37.7 USD, Sanara Medtech Inc is Undervalued by 9%.